💥 Fed cuts sparks mid cap boom! ProPicks AI scores with 4 stocks +23% each. Get October’s update first.Pick Stocks with AI

Williams-Sonoma Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Published 22/05/2024, 07:22
© Reuters.  Williams-Sonoma Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
WSM
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Williams-Sonoma, Inc. (NYSE:WSM) is set to release earnings results for its first quarter, before the opening bell on May 22.

Analysts expect the San Francisco, California-based company to report quarterly earnings at $2.68 per share, up from $2.64 per share in the year-ago period. Williams-Sonoma is projected to report quarterly revenue of $1.65 billion, according to data from Benzinga Pro.

On March 13, Williams-Sonoma posted better-than-expected earnings for its fourth quarter. The company announced a new $1 billion stock repurchase authorization and increased its quarterly dividend.

Williams-Sonoma shares fell 0.7% to close at $314.38 on Tuesday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

  • Wedbush analyst Seth Basham maintained an Outperform rating and raised the price target from $330 to $350 on May 17. This analyst has an accuracy rate of 72%.
  • Evercore ISI Group analyst Oliver Wintermantel maintained an In-Line rating and increased the price target from $310 to $315 on May 14. This analyst has an accuracy rate of 73%.
  • JP Morgan analyst Christopher Horvers upgraded the stock from Underweight to Neutral and boosted the price target from $245 to $275 on May 3. This analyst has an accuracy rate of 72%.
  • Telsey Advisory Group analyst Joseph Feldman maintained an Outperform rating and boosted the price target from $320 to $340 on March 25. This analyst has an accuracy rate of 73%.
  • Barclays analyst Adrienne Yih maintained an Underweight rating and raised the price target from $146 to $232 on March 15. This analyst has an accuracy rate of 69%.
Read This Next: Jim Cramer Calls This Healthcare Stock A ‘Worthy Spec,’ Recommends Avoiding Canada Goose

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.